1. Home
  2. OCUL vs TIPT Comparison

OCUL vs TIPT Comparison

Compare OCUL & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • TIPT
  • Stock Information
  • Founded
  • OCUL 2006
  • TIPT 2007
  • Country
  • OCUL United States
  • TIPT United States
  • Employees
  • OCUL N/A
  • TIPT N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • TIPT Property-Casualty Insurers
  • Sector
  • OCUL Health Care
  • TIPT Finance
  • Exchange
  • OCUL Nasdaq
  • TIPT Nasdaq
  • Market Cap
  • OCUL 957.3M
  • TIPT 808.7M
  • IPO Year
  • OCUL 2014
  • TIPT 2007
  • Fundamental
  • Price
  • OCUL $7.06
  • TIPT $21.36
  • Analyst Decision
  • OCUL Strong Buy
  • TIPT
  • Analyst Count
  • OCUL 10
  • TIPT 0
  • Target Price
  • OCUL $16.11
  • TIPT N/A
  • AVG Volume (30 Days)
  • OCUL 1.6M
  • TIPT 129.2K
  • Earning Date
  • OCUL 05-05-2025
  • TIPT 04-30-2025
  • Dividend Yield
  • OCUL N/A
  • TIPT 1.12%
  • EPS Growth
  • OCUL N/A
  • TIPT 107.58
  • EPS
  • OCUL N/A
  • TIPT 1.20
  • Revenue
  • OCUL $59,647,000.00
  • TIPT $2,042,059,000.00
  • Revenue This Year
  • OCUL $13.32
  • TIPT N/A
  • Revenue Next Year
  • OCUL $13.13
  • TIPT N/A
  • P/E Ratio
  • OCUL N/A
  • TIPT $17.81
  • Revenue Growth
  • OCUL N/A
  • TIPT 15.66
  • 52 Week Low
  • OCUL $4.06
  • TIPT $15.60
  • 52 Week High
  • OCUL $11.78
  • TIPT $26.90
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 44.18
  • TIPT 44.82
  • Support Level
  • OCUL $6.84
  • TIPT $21.03
  • Resistance Level
  • OCUL $8.90
  • TIPT $21.79
  • Average True Range (ATR)
  • OCUL 0.47
  • TIPT 0.67
  • MACD
  • OCUL -0.11
  • TIPT -0.06
  • Stochastic Oscillator
  • OCUL 10.71
  • TIPT 40.63

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About TIPT Tiptree Inc.

Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.

Share on Social Networks: